Evoke Wealth’s Idexx Laboratories IDXX Stock Holding History

Evoke Wealth’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-446	Closed	-$251K	–	298
2026 Q1	$251K	Buy	446 +10	+2%	+$6.41K	﹤0.01%	597
2025 Q4	$295K	Buy	436 +42	+11%	+$28.6K	0.01%	525
2025 Q3	$252K	Buy	+394	New	+$239K	0.01%	547
2022 Q4	–	Sell	-35	Closed	-$11K	–	726
2022 Q3	$11K	Buy	35 +3	+9%	+$1.1K	﹤0.01%	739
2022 Q2	$11K	Buy	32 +2	+7%	+$816	﹤0.01%	756
2022 Q1	$16K	Buy	30 +14	+88%	+$7.36K	﹤0.01%	690
2021 Q4	$11K	Hold	16	–	–	﹤0.01%	778
2021 Q3	$9K	Sell	16 -11	-41%	-$7.39K	﹤0.01%	759
2021 Q2	$17K	Buy	27 +11	+69%	+$6.07K	﹤0.01%	679
2021 Q1	$8K	Hold	16	–	–	﹤0.01%	726
2020 Q4	$8K	Hold	16	–	–	﹤0.01%	620
2020 Q3	$6K	Hold	16	–	–	﹤0.01%	627
2020 Q2	$5K	Hold	16	–	–	﹤0.01%	666
2020 Q1	$3.88K	Sell	16 -4	-20%	-$1.04K	﹤0.01%	665
2019 Q4	$5.22K	Hold	20	–	–	﹤0.01%	899
2019 Q3	$5.44K	Buy	+20	New	+$5.57K	﹤0.01%	984

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Evoke Wealth's IDXX Position: Q2 2026 in Review

Evoke Wealth sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 446 shares — an estimated $251K sold.

Evoke Wealth first reported a position in IDXX in Q3 2019 and held it in 16 quarters. The position peaked at $295K in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Evoke Wealth reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
Evoke Wealth sold 446 Idexx Laboratories shares in Q2 2026, an estimated $251K.
Evoke Wealth first reported a position in Idexx Laboratories in Q3 2019 and held it in 16 quarters.
Evoke Wealth's Idexx Laboratories position peaked at $295K in Q4 2025.
1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Evoke Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.